JARED YORK: Open Payments
NPI 1124332168 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 70 payments from 19 companies in 2025. Trend: 2023 $865 · 2024 $978 · 2025 $1,368
Food & beverage: $1,368
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $235 |
| Lilly USA, LLC | 10 | $157 |
| ABBVIE INC. | 9 | $148 |
| Corcept Therapeutics | 4 | $131 |
| PFIZER INC. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| SANOFI-AVENTIS U.S. LLC | 3 | $74 |
| Astellas Pharma US Inc | 3 | $53 |
| Dexcom, Inc. | 2 | $46 |
Products named: JARDIANCE, Korlym, Wegovy, VRAYLAR, MOUNJARO, AIRSUPRA, TZIELD, REXULTI.
Industry payments across TX — which companies pay providers there.
